Neuroendocrine lung tumours: new concept

W. Travis (Washington, United States Of America)

Source: Annual Congress 2004 - PG15 - Understanding the WHO 2004 histopathological classification of lung tumours and its clinical utility

Slide presentationPDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Travis (Washington, United States Of America). Neuroendocrine lung tumours: new concept. Annual Congress 2004 - PG15 - Understanding the WHO 2004 histopathological classification of lung tumours and its clinical utility

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Neuroendocrine tumours of the lung other than SCLC
Source: ERS webinar 2021: Neuroendocrine tumours of the lung other than SCLC
Year: 2021


Neuroendocrine lung carcinoma in a child
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009

Neuroendocrine carcinoma of the lung in a child
Source: Eur Respir J 2005; 26: Suppl. 49, 537s
Year: 2005

Neuroendocrine tumours
Source: International Congress 2015 – Lung cancer pathology
Year: 2015



Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas
Source: Eur Respir J 2004; 24: Suppl. 48, 557s
Year: 2004

Lung metastasis of thyroid carcinoma: misunderstanding of existing pathology
Source: Eur Respir J 2001; 18: Suppl. 33, 398s
Year: 2001

Neuroendocrine cells in lung development and disease
Source: Eur Respir Monogr 2021; 91: 44-55
Year: 2021


Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification
Source: Eur Respir J 2011; 38: 239-243
Year: 2011


Genetics, pathology, and therapy of neuroendocrine tumours of the lung
Source: International Congress 2017 – ME3 Genetics, pathology and therapy of neuroendocrine tumours of the lung
Year: 2017


Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease
Source: Eur Respir J 2014; 43: 1439-1447
Year: 2014



Clinicopathological prognostic factors in operated for small cell lung carcinoma or large cell neuroendocrine carcinoma patients
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013


Synchronous lung adenocarcinoma and intrapulmonary thymoma: A rare entity
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016


Pulmonary sarcomatoid carcinoma - The experience of a lung cancer unit
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016


Synchronous primary lung cancer with three separate tumors
Source: Annual Congress 2007 - Lung neoplasms
Year: 2007


Clinical characterization of non-small cell lung cancer tumors showing neuroendocrine differentiation
Source: Eur Respir J 2002; 20: Suppl. 38, 270s
Year: 2002

Large cell neuroendocrine carcinoma of the lung: Experience with 20 resected cases
Source: Eur Respir J 2003; 22: Suppl. 45, 250s
Year: 2003

mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013


Intrathoracic mass as an initial presentation of follicular carcinoma of thyroid: A rare entity
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015

Early surgical resection for stage I high-grade neuroendocrine caricinoma of lung
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016